Abstract
Acne vulgaris is the most common disease involving the pilosebaceous unit. It is rarely misdiagnosed. It occurs at the site where there are sebaceous follicles and thus occurs predominantly on the face, back and chest. It occurs in all races and affects both sexes. The onset of acne is usually in early adolescence and affects up to 80% of all individuals. The milder physiological acne which affects many adolescents will last for 4 or 5 years, but the more clinical varieties will last for 12, and sometimes even 40 or 50 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cunliffe WJ, Clayden AD, Gould D et al. (1981) Acne vulgaris - its aetiology and treatment. A review. Clin Exp Dermatol 6: 461–469
Katsambas A. (1998) Why and when the treatment of acne fails. What to do Dermatology 196: 158–161
Lyons RE (1978) Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris. Int J Dermatol 17: 246–251
Chalker DK, Lesher JL, Smith JG et al. (1987) Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: Results of a multicenter, double-blind investigation. J Am Acad Dermatol 17: 251–254
Shalita A, Weiss JS, Chalker DK, Elis CN, Greenspa A, Katz HI, Kantor I, Millikan LE, Swinhart T, Swinyer L, Whitmore C, Baker M, Czernielewski J (1996) A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 34: 482–485
Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM (1993) Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 306: 555–556
Schaefer H (1993) Penetration and percutaneous absorption of topical retinoids. A review. Skin Pharmacol 6: 17–23
Bottomley WW, Cunliffe W (1993) Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris. Dermatol 187: 193–196
Goulden V, Glass D, Cunliffe WJ (1996) Safety of long term high dose minocycline in the treatment of acne. Brit J Dermatol 134: 693–695
Seukeran DC, Eady AE, Cunliffe WJ (1997) Benefit-risk assessment of acne therapies. Lancet 349: 1251
Hammerstein J, Cupceancu B (1969) Behandlung des Hirsutismus mit Cyproteronacetat. Dtsch Med Wochenschr 94: 829–834
Strauss JS, Rapini RP, Shalita AR et al. (1984) Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 10: 490–496
Goulden V, Layton AM, Cunliffe WJ (1995) Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 190: 284–287
Cunliffe WJ, Van der Kerkhof PCM, Caputo R et al. (1994) Roaccutane treatment guidelines, results of an international survey. Dermatology: 351–357
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cunliffe, W.J., Seukeran, D.C. (2000). Acne. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03835-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-03835-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03837-6
Online ISBN: 978-3-662-03835-2
eBook Packages: Springer Book Archive